AF-CARE
The AF-CARE (Atrial Fibrillation screening with MobiCARE in subjects with health care examination) study is a prospective, multicenter cohort study among Korean individuals without previously diagnosed atrial fibrillation (AF) who underwent national health screenings or voluntary health checkups and had a CHA2DS2-VASc score ≥2.
This study aims:
To evaluate the effectiveness of a 7-day single-lead electrocardiogram (ECG) monitoring in detecting AF among Korean individuals undergoing routine health checkups who are at high risk of stroke
To explore its potential role in facilitating timely AF management to prevent stroke and improve QoL.
Current ESC guidelines have Class IIa recommendation of population-based screening using prolonged monitoring in high-risk population of stroke.
Adapted from the 2024 ESC Guidelines for the Management of Atrial Fibrillation, developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) (Van Gelder et al., European Heart Journal, 2024).
mobiCARE MC200M (Seers Technology, Korea) was used. AI-based algorithm was utilized to detect AF and classify other arrhythmias.
AF detection rate in mobiCARE was 1.48%, which was about 7 times higher than that of single-timepoint 12-lead ECG, which was 0.2%. An excess detection rate was 1.28%.
We only have cross-sectional data yet, but the results are promising. Follow-up data for 12 months are upcoming.
The baseline data was presented at the 68th Annual Scientific Meeting of the Korean Society of Cardiology, Seoul, on October 19, 2024. (https://ksc2024.or.kr/program/full/index.php)
